Table 1.
DCCT/EDIC study naïve and genome‐wide bootstrap bias‐reduced logHR estimates (taken in absolute value)
Univariable models | |||||||||
---|---|---|---|---|---|---|---|---|---|
Gene | SNP | MAF (%) | P‐value | Naïve logHR estimate | Genome‐wide bootstrap estimate | Percentage reduction of naïve by genome‐wide bootstrap | Power by naïve (%) | Power by genome‐wide bootstrap (%) | |
1 | LIPC | rs1968685 | 48.3 | 2.22 × 10−4 | 0.51 | 0.29 | 43.1 | 90.1 | 35.3 |
2 | LIPC a | rs7178362 | 13.7 | 2.36 × 10−4 | 0.56 | 0.22 | 60.1 | 63.4 | 7.7 |
3 | FLT1 | rs7999615 | 6.2 | 6.13 × 10−4 | 0.75 | 0.27 | 64.0 | 57.3 | 5.7 |
4 | SOD1 a | rs17880135 | 5.6 | 8.18 × 10−4 | 0.69 | 0.17 | 75.4 | 43.2 | 2.4 |
5 | VDR | rs2254210 | 36.3 | 2.61 × 10−3 | 0.39 | 0.16 | 59.0 | 60.4 | 7.9 |
6 | PRKCB1 | rs411103 | 39.2 | 3.82 × 10−3 | 0.41 | 0.16 | 61.0 | 67.7 | 8.2 |
7 | FLT4 | rs307806 | 14.9 | 3.85 × 10−3 | 0.46 | 0.12 | 73.9 | 46.4 | 3.8 |
8 | MMP2 | rs17859935 | 16.9 | 4.36 × 10−3 | 0.46 | 0.14 | 69.6 | 53.0 | 3.8 |
9 | ABCA1 a | rs2472448 | 10.6 | 5.00 × 10−3 | 0.86 | 0.46 | 46.5 | 91.5 | 32.2 |
10 | VEGFA | rs3025035 | 7.2 | 5.34 × 10−3 | 0.58 | 0.13 | 77.6 | 35.4 | 1.9 |
11 | PON1 a | rs854555 | 34.4 | 6.22 × 10−3 | 0.41 | 0.17 | 58.5 | 64.7 | 8.8 |
12 | UCP1 | rs2043125 | 26.5 | 6.52 × 10−3 | 0.46 | 0.17 | 63.0 | 69.3 | 7.5 |
13 | PARP1 a | rs3219065 | 15.9 | 7.75 × 10−3 | 0.41 | 0.09 | 78.0 | 38.0 | 1.9 |
14 | PARP1 a | rs2027440 | 15.9 | 8.18 × 10−3 | 0.41 | 0.08 | 80.5 | 38.0 | 1.6 |
15 | MMP2 | rs17859970 | 14.8 | 9.99 × 10−3 | 0.43 | 0.10 | 76.7 | 40.8 | 2.1 |
Minor allele is the risk allele, otherwise major allele is associated with risk.
Analysis of time to severe nephropathy (1,361 individuals with 115 events) based on a significance threshold selection criterion of P < 0.01. SNPs with MAF ≤ 5% are excluded. Bias reduction ranges from 43.1% to 80.5%. The final two columns display post hoc power calculations for a similar sample assuming logHRs are set to the value of the naïve or the genome‐wide bias‐reduced estimates.